Hanwen Lu
Liwei Zhou
Bingchang Zhang1,3
Yuanyuan Xie
Zhanxiang Wang
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1Department of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China
- 2Department of Neuroscience, Institute of Neurosurgery, School of Medicine, Xiamen University, Xiamen, China
- 3Department of Neurosurgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China
A corrigendum on
Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
by Lu, H., Zhou, L., Zhang, B., Xie, Y., Yang, H., and Wang, Z. (2022). Front. Med. 9:939776. doi: 10.3389/fmed.2022.939776
In the published article, there was an error in affiliation 1. Instead of “Department of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, Xiamen, China”, it should be “Department of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China”.
In the published article, there was an error in affiliation 2. Instead of “Institute of Neurosurgery, School of Medicine, Xiamen University, Xiamen, China”, it should be “Department of Neuroscience, Institute of Neurosurgery, School of Medicine, Xiamen University, Xiamen, China”.
In the published article, there was an error in affiliation 3. Instead of “Department of Neurosurgery, The First Affiliated Hospital of Xiamen University, Xiamen, China”, it should be “Department of Neurosurgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China”.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: Cuproptosis, glioma, prognostic biomarker, immune infiltration, lipoylation
Citation: Lu H, Zhou L, Zhang B, Xie Y, Yang H and Wang Z (2023) Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma. Front. Med. 10:1244638. doi: 10.3389/fmed.2023.1244638
Received: 22 June 2023; Accepted: 23 June 2023;
Published: 10 July 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Lu, Zhou, Zhang, Xie, Yang and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Zhanxiang Wang, V2FuZ1pYQHhtdS5lZHUuY24=
†These authors share first authorship